Results 221 to 230 of about 37,987 (275)
The research potential of A20 in psoriatic arthritis. [PDF]
Front ImmunolWan YW, Duan X, Jin Z, Chen H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Journal of Rheumatology Supplement, 2009
Early detection of psoriatic arthritis (PsA) can effectively help in reducing the risk of joint damage and disability. Accordingly, the authors offer diagnostic insights in order to improve the approach to the patient's medical history, clinical examination, and the imaging modalities.
Scarpa R. +6 more
openaire +4 more sources
Early detection of psoriatic arthritis (PsA) can effectively help in reducing the risk of joint damage and disability. Accordingly, the authors offer diagnostic insights in order to improve the approach to the patient's medical history, clinical examination, and the imaging modalities.
Scarpa R. +6 more
openaire +4 more sources
Rheumatic Disease Clinics of North America, 2005
In the majority of patients with psoriatic arthritis (PsA), it is a chronic progressive disease, and only 12% of patients with early PsA will be in disease-modifying antirheumatic drug-free remission at 2 years. Radiologic damage occurs in the early stages of PsA; up to 47% of patients with PsA have radiologic erosions after 2 years.
David, Kane, Sanjay, Pathare
openaire +2 more sources
In the majority of patients with psoriatic arthritis (PsA), it is a chronic progressive disease, and only 12% of patients with early PsA will be in disease-modifying antirheumatic drug-free remission at 2 years. Radiologic damage occurs in the early stages of PsA; up to 47% of patients with PsA have radiologic erosions after 2 years.
David, Kane, Sanjay, Pathare
openaire +2 more sources
Early psoriatic arthritis: facing the challenge
British Journal of Nursing, 2013Early diagnosis and initiation of therapy has become a primary objective in clinical rheumatology. As psoriatic arthritis causes deformities and joint damage leading to impaired quality of life and function as well as increased mortality risk, there was an urgent call for action aiming at inducing remission of the active inflammatory process.
Deborah, Palmer, Y, El Miedany
openaire +2 more sources
The early phase of psoriatic arthritis
Annals of the Rheumatic Diseases, 2011Evaluation of the preclinical phases of the classic autoimmune diseases including rheumatoid arthritis has been facilitated by the availability of autoantibody and genetic markers that point firmly towards the early dysregulation of the adaptive immune responses.
Dennis, McGonagle +4 more
openaire +2 more sources
Treatment strategies for early psoriatic arthritis
Expert Opinion on Pharmacotherapy, 2009Until a few years ago, the early diagnosis of psoriatic arthritis (PsA) did not receive much attention, especially in view of the lack of drugs capable of altering the disease course. This changed with the introduction of the TNF-alpha-blocking agents, as a result of which the early diagnosis of PsA is now a topic of great interest.The aim of the study
Ignazio, Olivieri +3 more
openaire +2 more sources
Sensitivity of the Classification of Psoriatic Arthritis Criteria in Early Psoriatic Arthritis
The Journal of Rheumatology, 2009Objective.To determine the sensitivity of the CASPAR criteria in patients with early psoriatic arthritis (PsA).Methods.Consecutive patients with a clinical diagnosis of PsA and a disease duration < 12 months were enrolled for study. The proportion of patients meeting the criteria (i.e., the sensitivity) was determined.Results.Forty-four patients ...
Salvatore, D'Angelo +6 more
openaire +2 more sources